Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.
Section 549.0206 - [Effective 4/1/2025] Submission Of Evidence To Support Including Drug On Preferred Drug Lists(a) In this section, "labeler" and "manufacturer" have the meanings assigned by Section 549.0101.(b) The commission shall ensure that a manufacturer or labeler may submit written evidence that supports including a drug on the preferred drug lists before a supplemental rebate agreement is reached with the commission. (Gov. Code, Sec. 531.072(e) (part).)Tex. Gov't. Code § 549.0206
Added by Acts 2023, Texas Acts of the 88th Leg.- Regular Session, ch. 769,Sec. 1.01, eff. 4/1/2025.